Search clinical trials for: Iodixanol-320

Total 4932 results

Bracco Diagnostics, Inc

Terminated

Kidney Damage In Patients With Severe Fall In eGFR

Coronary Artery Stenosis

Canada
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Moderate Fall in eGFR

Coronary Artery Stenosis

Canada, United States
Deutsches Herzzentrum Muenchen

Completed

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

Renal Insufficiency, Chronic | Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Azienda Sanitaria Locale 9, Grosseto

Completed

Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship (DrKILDARE)

Contrast Induced Acute Kidney Injury

Italy
GE Healthcare
Quintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion...

Terminated

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Diabetes Mellitus | Renal Insufficiency

United States, United Kingdom
GE Healthcare

Completed

Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

Coronary Artery Disease

France
GE Healthcare

Completed

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography

Coronary Artery Disease | Renal Impairment

Sweden
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
Seoul National University Hospital

Completed

RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography

Kidney Failure

Korea, Republic of
GE Healthcare

Completed

Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

Coronary Artery Disease | ST-segment Elevation Myocardial Infarction

China, Korea, Republic of
GE Healthcare

Withdrawn

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Diabetes Mellitus | Renal Impairment | Coronary Artery Disease (CAD)

United States, Germany
GE Healthcare
i3 Statprobe

Completed

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Patient Comfort and Safety

United States
Yong Huo

Unknown

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction (RIPE)

Kidney Failure, Chronic

China
Minneapolis Heart Institute Foundation

Recruiting

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography (GE OCT)

Coronary Artery Disease | Contrast Media Reaction

United States
GE Healthcare
i3 Statprobe

Completed

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Drug Safety

United States
Seoul National University Bundang Hospital

Completed

Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

Chronic Renal Insufficiency | Coronary Angiography

Korea, Republic of
Oslo University Hospital

Completed

Novel Imaging of the Eustachian Tube; Patient Study (CT-ET)

Otitis Media With Effusion | Eustachian Tube Disorder

Norway
Instituto Dante Pazzanese de Cardiologia

Unknown

Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial) (IDPC)

Acute Kidney Failure
Ospedale San Donato
Ospedale Le Scotte; Ospedale della Misericordia - Grosseto

Completed

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) (CONTRAST-AMI)

Acute Myocardial Infarction | Contrast Induced Nephropathy

Italy
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Healthy

United States
Chinese PLA General Hospital

Completed

A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients (DIRECT)

Kidney Failure, Chronic

China
University of Washington
Guerbet

Withdrawn

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Malignant Neoplasm in the Head and Neck | Metastatic Malignant Neoplasm in the Head and Neck

United States
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Normal eGFR

Coronary Artery Stenosis

United States
Stanford University

Terminated

Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

Pancreatic Cancer

United States
Woolcock Institute of Medical Research
University of Sydney

Completed

Cannabinol Use in Patients With Insomnia Disorder (CUPID)

Insomnia Disorder

Australia
Marval Pharma Ltd.

Terminated

Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers

Healthy Volunteers

United States
Bracco Diagnostics, Inc

Completed

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Peripheral Arterial Occlusive Disease

United States
Norwegian University of Science and Technology

Completed

DynaCT in Preoperative Imaging Before Insertion of Stentgraft (DynaCT)

Abdominal Aortic Aneurysm

Norway
Medical University of South Carolina
General Electric

Completed

Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan

Aortic Valve Stenosis

United States
Guangdong Provincial People's Hospital
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaborators

Terminated

Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients (NEIHR)

Chronic Renal Disease

China
Bracco Diagnostics, Inc

Terminated

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients (RECARE)

Diabetes Mellitus | Chronic Renal Impairment

United States
VA Greater Los Angeles Healthcare System

Withdrawn

Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli

Multiple Pulmonary Emboli

United States
University of Edinburgh
NHS Lothian

Completed

Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material

Radiocontrast-induced Nephropathy

United Kingdom
Duke University

Completed

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Coronary Computed Tomographic Angiography
Bracco Diagnostics, Inc

Completed

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

Peripheral Arterial Occlusive Disease
AbbVie

Completed

A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

Ulcerative Colitis (UC)

United States, Canada, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
Novartis
The TIMI Study Group

Completed

Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

Myocardial Ischemia | Post Acute Coronary Syndrome

Germany, Spain, United States, Belgium, Canada, Czech Republic, Hungary, Netherlands, Poland, Russian Federation, Sweden
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Essential Hypertension
Medtronic BRC
Medtronic

Completed

Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study (RARE-PEARL)

Permanent Atrial Fibrillation

Italy
GE Healthcare
Bayer; Guerbet/Liebel-Flarsheim

Withdrawn

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

Hypothyroidism
PreCision Dermatology, Inc.

Unknown

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Rosacea

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Recruiting

Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)

Acute Malaria

Burkina Faso, Gabon, Mozambique, Uganda
Fundació Institut de Recerca de l'Hospital de la...
Sociedad Española de Neumología y Cirugía Torácica

Unknown

Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis

Bronchiectasis

Spain
Rush University Medical Center

Withdrawn

Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms

Chronic Low-back Pain | Peripheral Neuropathy | CRPS
MedImmune LLC

Completed

Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease

Cardiovascular Disease | Atherosclerosis

United States
Hepatopancreatobiliary Surgery Institute of Gansu...

Completed

Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications

Complications

China
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

Hypertension

Search clinical trials for: Iodixanol-320

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations